昭衍新药连续3个交易日收盘价格涨幅偏离值累计超20%

财中社
Sep 15

  昭衍新药(603127/06127)发布公告,公司股票在2025年9月11日、9月12日和9月15日连续3个交易日,收盘价格涨幅偏离值累计超过20%。

  2025年中期,昭衍新药实现收入6.69亿元,归母净利润6093万元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10